DK:BAVA

A Copenhagen company worked for nearly two decades to develop a vaccine and only six governments bought it. Within the last few weeks, orders have come in from dozens of countries around the globe and it is looking at whether it can operate 24-hours a day, seven days a week, to meet demand. The World Health Organization in recent days declared the disease a public health emergency of international concern, the first time the group has issued that designation since the early days of the Covid-19 pandemic.…

The Food and Drug Administration signed off on a Bavarian Nordic A/S monkeypox vaccine plant, a move that allows use in the U.S. of 786,000 doses made at the facility in Denmark. The FDA said Wednesday it had validated the quality of the shots made at the plant and they met the agency’s standards. “This action by the FDA is a critical step forward in our plans to strengthen and accelerate our monkeypox response, which includes distributing a…

Danish vaccine maker Bavarian Nordic A/S is making more of a smallpox vaccine typically stockpiled in case of biological warfare, as governments seek doses that also offer protection against monkeypox amid an unusual outbreak around the world. Monkeypox, a viral illness that is only rarely detected outside of Africa, has been reported in recent weeks in at least 17 countries including the U.S., U.K., Spain, Portugal and Australia, according to nonprofit data platform Global.health. In the…